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Abstract
Background: The SH2-containing-59inositol phosphatase-1 (SHIP) influences signals downstream of cytokine/chemokine
receptors that play a role in megakaryocytopoiesis, including thrombopoietin, stromal-cell-derived-Factor-1/CXCL-12 and
interleukin-3. We hypothesize that SHIP might control megakaryocytopoiesis through effects on proliferation of
megakaryocyte progenitors (MKP) and megakaryocytes (MK).
Methodology and Principal Findings: Herein, we report the megakaryocytic phenotype and MK functional assays of
hematopoietic organs of two strains of SHIP deficient mice with deletion of the SHIP promoter/first exon or the inositol
phosphatase domain. Both SHIP deficient strains exhibit a profound increase in MKP numbers in bone marrow (BM), spleen
and blood as analyzed by flow cytometry (Lin
2c-Kit
+CD41
+) and functional assays (CFU-MK). SHIP deficient MKP display
increased phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT-3), protein kinase B (PKB/AKT) and
extracellular signal-regulated kinases (ERKs). Despite increased MKP content, total body number of mature MK (Lin
2c-
kit
2CD41
+) are not significantly changed as SHIP deficient BM contains reduced MK while spleen MK numbers are increased.
Reduction of CXCR-4 expression in SHIP deficient MK may influence MK localization to the spleen instead of the BM.
Endomitosis, process involved in MK maturation, was preserved in SHIP deficient MK. Circulating platelets and red blood
cells are also reduced in SHIP deficient mice.
Conclusions/Significance: SHIP may play an important role in regulation of essential signaling pathways that control early
megakaryocytopoiesis in vivo.
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Introduction
SH2-containing-59inositol phosphatase-1 (SHIP) can catalyze
the removal of the 59 phosphate group from phosphatidylinositol-
3,4,5-phosphate (PIP3) and inositol-1,3,4,5–tetrakisphosphate
(IP4) [1,2]. In this manner, SHIP can prevent the recruitment of
pleckstrin homology containing proteins to the plasma membrane
or prevent calcium uptake and thus regulate survival, proliferation
and activation of hematopoietic cells [3,4]. SHIP deficiency has
profound functional and pathological consequences as SHIP
mutant mice suffer from osteoporosis [5], and a myeloproliferative
disorder that leads to lung consolidation [6]. Analysis of SHIP
mutant mice has demonstrated a pivotal role for SHIP in vivo in
regulating the homeostasis of various cell types including tissue
macrophages, osteoclasts, myeloid, natural killer (NK) and
hematopoietic stem cells (HSC) [4–7]. We have shown that
despite expansion of the HSC compartment, SHIP deficient mice
have reduced long-term engraftment capacity and have an altered
homing capacity due to reductions in key chemotaxis and
adhesion receptors [8]. Furthermore, SHIP deficient mice have
a promiscuous NK cell repertoire that permits engraftment of
completely mismatched bone marrow (BM) without graft-versus-
host disease [7].
SHIP is known to influence signaling pathways downstream of
receptors for chemokines and cytokines involved in megakaryo-
cytopoiesis and thrombopoiesis, such as thrombopoietin (TPO) [9–
12], Stromal-cell-derived-Factor 1 (SDF-1/CXCL-12), [13–16]
and interleukin (IL)-3 [17]. TPO influences megakaryocyte (MK)
development by controlling proliferation, differentiation, survival
and endoduplication [18]. Circulating platelets sequester free
TPO, and thereby limit megakaryocytopoiesis during steady-state
hematopoiesis [19–23]. Upon binding of TPO to its receptor, c-
mpl, phosphatidylinositol 3-kinase (PI3K) and mitogen-activated
protein kinase (MAPK) pathways are activated promoting cycling
and survival of MK [9,24,25]. TPO binding to c-mpl also leads to
SHIP phosphorylation [9], which may be a negative regulator of
these signaling pathways. Furthermore, Lyn kinase deficient mice
have an increased MK progenitor pool associated with a reduction
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inhibition [26].
SDF-1/CXCL12 induces transendothelial MK migration and
platelet production in vitro {Hamada, et al 1998, Wang, et al 1998}
and increases platelets in NOD/SCID and Balb/c mice [15,27].
We have shown that SDF-1 enhances human thrombopoiesis in
xenotransplanted NOD/SCID mice [28]. SDF-1 and fibroblast
growth factor-4 allow hematopoietic progenitors to relocate to a
BM microenvironment that is permissive and instructive for MK
maturation and thrombopoiesis [29]. SHIP deficient myeloid
progenitors exhibit enhanced chemotaxis towards SDF-1/CXCL-
12, indicating that SHIP influences signaling downstream of its
receptor, CXCR-4 [30]. However, our recent demonstration that
SHIP deficiency reduces both the surface density of CXCR-4 and
homing of HSC indicates SHIP deficiency can also compromise
CXCR-4 signaling [8].
It has been reported that SHIP deficient BM have decreased
number of colony-forming-unit megakaryocytes (CFU-Mk) [31],
and SHIPhasalsobeenshowntoregulate PIP3levelsafterthrombin
or collagen induced platelet activation [32,33]. Based on the defined
role for SHIP in signaling pathways for cytokine/chemokines that
also regulate MK and platelet biology, we hypothesized that SHIP
might be involved in the regulation of megakaryocytopoiesis and
plateletproduction in vivo. Herein,wereportthat twostrains of SHIP
deficient mice exhibit increased numbers of megakaryocyte
progenitors (MKP) in hematopoietic organs as determined by flow
cytometry (Lin
2c-Kit
+CD41
+) and functional assays (colony forming
unit (CFU)-MK). Despite the increase in MKP, mature MK (Lin
2c-
Kit
2CD41
+) numbers are not significantly changed since MK
redistribute to other organs in the SHIP deficient animal. Moreover,
MK endoduplication function is preserved in SHIP deficient MK, as
well as circulating platelet numbers, which are not proportionally
increased as would be expected. Interestingly, SHIP deficient MKP
exhibit increased phosphorylation of Signal Transducers and
Activators of Transcription 3 (STAT-3), protein kinase B (PKB/
AKT) and extracellular signal-regulated kinases (ERKs). Further-
more,CXCR-4surfaceexpressionisreducedonSHIPdeficientMK
as we previously showed for HSC [8] contributing, in part, to
localization of MK progenitors to peripheral hematopoietic organs.
These findings suggest that SHIP might be important for the control
of early MK development.
Results
SHIP deficient bone marrow, spleen and blood contain
increased numbers of functional MKP
Histological evaluation of Hematoxylin-Eosin stained spleens
from two strains of SHIP deficient mice revealed that there is an
impressive infiltrate of morphologically appearing MK. BM
histopathology revealed that MK in SHIP deficient (SHIP
2/2)
BM are equally represented compared to wild type (WT) control.
MK morphology in SHIP deficient mice showed that they are
hypolobulated micro-MK when compared to WT BM which
contained hyperlobulated MK (Figure 1A). Immuno-staining with
anti-Glycoprotein IIB-IIIA (CD41a) antibody corroborated the MK
lineage nature of the cells observed in spleen and BM (Figure 1B).
To further characterize the megakaryocytic compartment in
SHIP deficient mice, we assessed the presence of early MKP,
immuno-stained as Lin
2c-Kit
+CD41
+, and of more differentiated
MK, identified as Lin
2c-Kit
2 CD41
+ (Figure 2A) [34]. The MKP
(Lin
2c-Kit
+CD41
+) compartment in the BM, spleen and peripheral
blood (PB) of both SHIP deficient mice (SHIP
2/2 and SHIP
DIP/DIP)
was increased as compared to WT mice (Figure 2B). In BM, there
was a mean 18.1 fold and 50 fold increase in SHIP
2/2 and
SHIP
DIP/DIP as compared to their WT littermates, respectively. The
absolutenumberofsplenicMKPwasincreasedbymorethan30fold
in both strains of mice. SHIP
2/2 PB contained fewer MKP (3 to 5
MKP/ml), but MKP numbers were significantly higher in
SHIP
DIP/DIP mice compared to control mice (Figure 2B). We then
combined the number of MKP present in the BM and spleen in
SHIP deficient mice to establish the total MKP body number. In
both mice strains (SHIP
2/2 and SHIP
DIP/DIP), the total MKP pool
was increased by a mean of 3.5 fold as compared to their respective
WT littermates (Figure 2C).
To further evaluate the functional capacity of MK precursors
(MKP) in SHIP deficient hematopoietic organs, we determined
CFU-MK activity in both the spleen and BM. We observed an
increased CFU-MK content in SHIP deficient BM although the
difference did not reach statistical significance (p.0.05). CFU-MK
in SHIP deficient spleen were statistically significantly increased
(p,0.05) compared to WT, corroborating flow cytometry findings
(Figure 2D).
Figure 1. MK morphology and Glycoprotein IIB-IIIa (CD41)
immunostain in BM and spleen of SHIP deficient mice. (A).
Hematoxylin-Eosin staining of BM and spleen of SHIP
2/2 (2/2) and
wild type (WT) littermate controls. Spleen of SHIP deficient mice is
characterized by a massive infiltrate with morphologically appearing
MK (left panel) compared to WT littermates (right panel). BM of SHIP
2/2
mice contained hypolobulated micro-MK compared to hyperlobulated
MK in WT BM. Magnification: 660. Results are representative of those
obtained in 3 animals per experimental group (B). Glycoprotein IIB-IIIA
(CD41) immuno-histochemistry. Spleen of SHIP
2/2 mice contained a
higher percentage of CD41
+ cells compared to WT spleen. Magnifica-
tion: 640. BM of SHIP deficient mice contained comparable number of
CD41
+ cells compared to WT. Magnification: 660.
doi:10.1371/journal.pone.0003565.g001
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phenotype in SHIP
2/2 (2/2) and SHIP
DIP/DIP (DIP/DIP) mice. Shown are representative flow cytometry dot plots of CD41 (x-axis) versus c-Kit (y-axis)
after gating on live and Lin
2 cells. MKP (Lin
2c-Kit
+CD41
+) are represented in the right upper quadrants and MK (Lin
2c-Kit
2CD41
+) are represented in
the right lower quadrants. Percentages for each population are indicated on each plot. (B) Represented are the mean6standard error mean (SEM)
(n=4 for experimental groups WT C57Bl6 and SHIP
2/2, while n=6 for experimental groups WT 129SvJ and SHIP
DIP/DIP) of the absolute numbers of
MKP in BM, spleen and PB of SHIP deficient mice (black columns) compared to respective WT littermates (gray columns). Mice strains specified in the
graphs. (C) Represented is the mean6SEM (n=4 for experimental groups WT C57Bl6 and SHIP
2/2, while n=6 for experimental groups WT 129SvJ
and SHIP
DIP/DIP) of total body MKP numbers determined as the calculated sum of MKP in one whole spleen plus MKP in one femur616.6 (since one
femur is estimated to contained 6% the total marrow) [3]. (D) Represented is the mean6SEM of CFU-MK colonies in BM and spleen of SHIP
2/2 (n=7)
and WT (n=7) littermates. Statistical analysis was established using the Mann-Whitney test. p values indicated on each graph.
doi:10.1371/journal.pone.0003565.g002
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Despite anincrease intotal MKP numbersinbothstrains of SHIP
deficient mice, BM MK content was decreased by a mean 2 fold in
SHIP
2/2 and SHIP
DIP/DIP while the absolute number of splenic
MK was increased by a mean 10.9 fold in SHIP
2/2 spleen and an
even more dramatic increase in SHIP
DIP/DIP spleen. Furthermore,
SHIP
2/2 PB showed a mean 7.7 fold increase in the absolute
number of MK and the same trend was observed for SHIP
DIP/DIP
mice (Figure 3A). Nevertheless the total MK content in SHIP
deficient mice was equivalent to WT littermates (Figure 3B). These
observations suggest a shift in the site of megakaryocytopoiesis from
the BM to the spleen. This is in agreement with other findings
suggesting that the spleen of SHIP deficient mice becomes a site of
intense extramedullar hematopoiesis [3,6,8].
SHIP deficient MK have reduced CXCR-4 surface
expression
We identified that SHIP
2/2 HSC have fewer CXCR-4 receptors
indicating that SHIP deficiency may also compromise SDF-1/
CXCR-4 signaling in hematopoietic cells [8]. CXCR-4
+ cells
mobilize towards an increased SDF-1 gradient determining their
localization to the BM, the organ with highest SDF-1 concentration
[14,16,29]. In order to address whether increased MK content in
spleen is due to migration between organs we evaluated CXCR-4
expression in SHIP deficient MK. Flow cytometry analysis revealed
that BM SHIP
2/2 MK exhibit a significant reduction in CXCR-4
expression as compared to WT MK (Figure 4A). The mean
fluorescence intensity (MFI) for CXCR-4 on SHIP
2/2 MK was
1.2960.06 610
4, while it was 3.1260.45 610
4 in WT littermates
(Figure 4B). This mean 2.4 fold decrease in CXCR-4 expression in
BM SHIP
2/2 MK may influence the ability of these cells to home
and/or be retained in the BM.
Figure 3. SHIP deficient mice MK are redistributed within
hematopoietic organs. (A) Represented are the mean6SEM (n=4 for
experimental groups WT C57Bl6 and SHIP
2/2, while n=6 for
experimental groups WT 129SvJ and SHIP
DIP/DIP) of the absolute
numbers of MK (Lin
2c-Kit
2CD41
+) in BM, spleen and PB of SHIP
deficient mice (black columns) compared to respective WT littermates
(gray columns). Mice strains specified in the graphs. (B) Represented is
the mean6SEM (n=4 for experimental groups WT C57Bl6 and SHIP
2/2,
while n=6 for experimental groups WT 129SvJ and SHIP
DIP/DIP) of total
body numbers of MK determined as the calculated sum of MK numbers
in one whole spleen plus MK in one femur 616.6 (since one femur is
estimated to contain 6% of the total marrow) [3]. Significance was
established using the Mann-Whitney test. p values indicated on each
graph.
doi:10.1371/journal.pone.0003565.g003
Figure 4. SHIP
2/2 MK have lowered CXCR-4 receptor expres-
sion. (A) Histogram representing the level of CXCR-4 receptor
expression on SHIP
2/2 (black line) and WT (gray line) Lin
2c-kit
2CD41
+
cells in BM. Isotype antibody control indicated in the histogram. (B)
Represented is the mean6SEM of the mean fluorescence (MFI) intensity
of CXCR-4 expression on SHIP
2/2 (2/2) (n=4) and WT (n=4) Lin
2c-
kit
2CD41
+ in BM. Significance was established using the Mann-Whitney
test. p values indicated in each graph.
doi:10.1371/journal.pone.0003565.g004
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SHIP is known to negatively influence signaling proteins
downstream of cytokine receptors involved in MK differentiation
and/or development; therefore we assessed phosphorylation of the
major signaling proteins in SHIP deficient MKP. We observed as
expected that SHIP
DIP/DIP BM MKP exhibit enhanced STAT-3,
Erk1/2 and Akt phosphorylation (P) when compared to WT as
determined by flow cytometry (Figure 5A). SHIP
DIP/DIP MKP
exhibited an average 1.5 fold increased in MFI values for P-
STAT3, P-Erk, and P-Akt (Figure 5B). Interestingly, there were no
significant differences in the percentage of cells containing P-Stat3,
P-Erk1/2 and P-Akt (data not shown) between SHIP
DIP/DIP MKP
and WT MKP, but rather a difference in the level of
phosphorylation on a per cell basis.
SHIP deficient MK precursors preserve endomitosis
function
Megakaryocytic precursors, unlike other cells, continue to
synthesize DNA during differentiation. We next evaluated the
ploidy distribution of SHIP
2/2 Lin
2CD41
+ selected cells that
morphologically appeared to have fewer nuclei lobules (micro-
MK) compared to hyperlobulated MK in WT BM as shown in
Figure 1. DNA content of Lin
2CD41
+ cells was determined by
flow cytometry on BM cells and splenocytes from SHIP
2/2 and
WT mice, after enriching for CD41
+ cells and staining with
propidium iodide (Figure 6A). Ploidy distribution in SHIP
deficient mice was similar to wild type littermates (p.0.05), thus,
having a comparable ability to mature properly as endomitosis is
an obligatory step towards differentiation (Figure 6B).
Figure 5. Increased phosphorylation of signaling proteins in SHIP
2/2 MKP in BM. (A) Histogram representing the level of phospho-STAT3,
phospho-Erk1/2 and phospho-Akt in Lin
2c-kit
+CD41
+ BM cells isolated from SHIP
2/2 (black line) and WT (gray line) mice. Isotype antibody control
indicated on the histogram. (B) Represented is the mean6SEM of the mean fluorescence (MFI) intensity of phospho-STAT3, phospho-Erk1/2 and
phospho-Akt on SHIP
2/2 (2/2) (n=4) and WT (n=4) Lin
2c-kit
+CD41
+ in BM. Significance was established using the Mann-Whitney test. p values
indicated on each graph.
doi:10.1371/journal.pone.0003565.g005
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and red blood cells
Since MK numbers are not increased in SHIP deficient mice
despite the increased MKP pool, we next evaluated whether
terminal MK differentiation into circulating platelets was pre-
served in these mice. Analysis of SHIP
2/2 and SHIP
DIP/DIP PB by
hematolizer revealed that these mice have a statistically significant
reduction in their platelet numbers as compared to WT littermates
(Table 1). Furthermore, both strains of SHIP mutant mice have a
significantly lower hematocrit percentage compared to WT
littermates (Table 1). It remains to be determined whether
thrombocytopenia could be related to hypersplenism due to
significant increased spleen size in SHIP deficient mice [3,6,8].
Discussion
Using two strains of SHIP mutant mice with either deletion of
the SHIP promoter/first exon (SHIP
2/2 mice) [7] or the inositol
phosphatase domain (SHIP
DIP/DIP) [35], we report that ablation of
SHIP results in an increased number of early megakaryocyte
progenitors (Lin
2c-Kit
+CD41
+-MKP) in BM, spleen and PB of
SHIP deficient mice as determined by flow cytometry and
functional assay (CFU-MK). SHIP deficient MKP showed
enhanced activation of STAT-3, AKT and ERK
SHIP deficient MKP altered phenotype could be related to
unknown intrinsic mechanism and/or related to the cytokine profile
of these mice. SHIP deficient mice are characterized by an
inflammatory state associated with increased numbers of inflamma-
torycells[6].SHIPdeficient micehavebeenshowntohaveincreased
levels of IL-6 [5] and TPO (Kerr et al, unpublished results) that could
contribute to enhance megakaryocytopoiesis in these mice.
In contrast, the total number of differentiated megakaryocytes
(Lin
2c-Kit
2CD41
+ MK) was unaltered in SHIP deficient mice.
Furthermore, DNA endoduplication was not affected in SHIP
deficient megakaryocytes. However, MK were predominately
localized to the spleen and blood with decreased numbers in the
BM. We postulate that aberrant MK localization could be related
to extramedullary hematopoiesis of SHIP deficient mice since they
have increased HSC content in the spleen [3,8] and/or related to
MK migration. We have shown that MK (Lin
2c-Kit
2CD41
+)
Figure 6. SHIP deficient MK precursors preserve endomitotic function. BM and splenocytes from SHIP
2/2 and WT mice were enriched for
CD41
+ on AutoMACS, stained with Lin-panel and CD41-biotin/SA-APC, fixed/permeated and stained with PI in the presence of RNase. (A)
Representative density plots of ploidy distribution of megakaryocytic cells. Lin
2CD41
+ cells were first selected by gating forward and side scatter by
area and width. Propidium iodide (x axis) versus forward side scatter (y axis) density plots were then generated to assess ploidy distribution in BM (top
panels) and spleen (bottom panels) of SHIP
2/2 and WT mice. (B) Represented is the mean6SEM (n=4 for each experimental group) percentage of
BM (top) and spleen (bottom) Lin
2CD41
+ cells in different ploidy stages from 2N to 32 N. Statistical analysis was done using the Mann-Whitney test. p
values indicated on each graph.
doi:10.1371/journal.pone.0003565.g006
Table 1. Platelet and Hematocrit counts in SHIP-deficient
mice.
Mice genotype Platelet levels (#610
3/ml) Hematocrit (%)
SHIP
2/2 (n=6) 672.8643.4
{ 42.561.4
*
SHIP
+/2 (n=10) 848.9635.7 45.260.5
SHIP
+/+ (C57Bl6) (n=12) 803.7631.5 46.660.5
SHIP
DIP/DIP(n=5) 455.4681.1
{ 43.161.4
{
SHIP
+/DIP(n=9) 652.3628.0 46.860.5
SHIP
+/+(129SvJ)(n=8) 647.9628.0 47.060.6
*p.0.05 compared to their respective WT littermates.
{p,0.05 compared to their respective WT and SHIP heterozygous littermates.
doi:10.1371/journal.pone.0003565.t001
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contribute to their spleen localization instead of retention to the
BM space given the higher SDF-1 concentration in this organ.
SHIP deficient mice also exhibit decreased number of platelets
as previously shown [31]. In addition, both strains of SHIP
deficient mice exhibit a decrease in hematocrit percentages as
previously shown in F6-7 SHIP
2/2 mice [31]. This finding
suggests that SHIP may be involved in modulating signaling
pathways of early precursors involved in both the MK and
erythroid lineages.
In conclusion, our results suggest that SHIP negatively controls
pathways promoting early megakaryocytopoiesis without compro-
mising mechanism underlying megakaryocytic endomitosis. In-
creased MKP compartment without a proportional increase of
more differentiated MK and platelets in SHIP deficient mice may
support the hypothesis that early megakaryocytopoiesis and late
megakaryocyte development and platelet shedding may be
regulated by distinct mechanisms.
Materials and Methods
Mice strains
SHIP
2/2 mice (F9 or F106C57BL6/J) produced in our
laboratory have a deletion of the SHIP promoter and first exon
[7]. A second SHIP deficient mouse model was also analyzed,
SHIP
DIP/DIP (129SvJ) [36], in which the inositol phosphatase
domain is deleted (kindly provided by Dr. Jeffrey Ravetch,
Rockefeller University, NY, USA). All studies described herein
were conducted on six to eight week-old adult mice. Experiments
were performed in compliance with institutional guidelines of the
University of South Florida.
Cell isolation
Isolation of BM cells and splenocytes was as described
previously [8]. Following red blood cell (RBC) lysis, the cells were
resuspended in staining media [8]. PB was obtained from the
retro-orbital sinus, sub-mandibular, or heart. For MKP analysis of
PB, RBC were lysed twice in 16 RBC lysis buffer (eBioscience).
Cells were then resuspended for antibody staining.
Flow cytometry analysis and antibodies
Staining of MKP and MK was performed as per Hodohara et al
[34]. All antibodies were from BD Biosciences except when
mentioned. The cells were treated with anti-CD16/CD32 (2.4G2)
to block Fc receptors and then stained with a Lin panel-PE, CD41-
FITC (MWReg30), and c-Kit-APC (2B8). The Lin- panel was
CD3e (17A2), CD4 (GK1.5), CD8a (53-6.7), B220 (RA3-6B2), Gr-
1 (RB6-8C5), Mac-1 (M1/70) (Caltag, Burlingame, CA) and
Ter119 (TER-119). Dead cells were excluded using 7-AAD (BD
Biosciences). Data was acquired on a FACS Calibur using the
FACS Quest software and analysis was done using FlowJo 4.5. For
the CXCR-4 analysis, the antibodies mentioned above were used
to define the MKP population. CXCR-4 antibody (2B11/CXCR-
4) conjugated to biotin was added to the stain, which was revealed
using a streptavidin-PeCy7 antibody. For this stain, dead cells were
excluded using DAPI (Sigma-Aldrich) and data was acquired on a
FACS LSR (BD Dickenson).
Platelet analysis
Blood was collected by heart puncture using a 25 gauge needle
with an EDTA coated 1 ml syringe, or by sub-mandibular bleed.
For each method the blood was collected directly into microtainer
K2EDTA tubes (BD, Franklin, NJ, USA). 200 ml of blood (either
diluted 1:4 or whole blood) was then analyzed on the CellDyn
3700 hematology analyzer using the Veterinary Package Software
(Abbott Diagnostic, Dallas, Texas USA), with a ratio to default
corresponding to the mice strain studied.
Histopathology
Bone and spleen were fixed in 10% buffered paraformaldehyde.
Bones were first decalcified using Routine Acid Decalcification
(RDO; Apex engineering Products, Plainfield, IL, USA), followed
by sectioning. The spleen and bone sections were then stained with
Hematoxylin-Eosin after being deparaffinized with xylene or
stained with Glycoprotein IIB-IIIA (CD41) antibody. Briefly, slides
were stained using the modified Meyer’s Hematoxylin and Eosin
phloxine B solution (Fisher Scientific, Suwanee, GA, USA)
according to a modified Armed Forces Institute of Pathology
(AFIP) protocol. Cells were visualized on a Leica DM LB
microscope. Pictures were taken using a RTcolor Spot camera
(Diagnostic Instrument Inc) with Spot Advance v3.0 software.
Ploidy assay
BM cells were isolated from hind/fore limb and vertebral
column. Briefly, cells were incubated on ice with CD41-biotin
antibody (Serotec, Raleigh, NC, USA) and then with anti-biotin
beads (Miltenyi Biotec) at 4uC. CD41
+ cells were then selected
using the autoMACS (Miltenyi Biotec). Collected CD41
+ cells
were stained with Lin panel-FITC as mentioned above and with
streptavidin-APC (BD Biosciences). The cells were fixed in 1%
formaldehyde (Sigma-Aldrich) for 15 minutes on ice and then
incubated overnight in a 70% ethanol solution at 220uC. The day
after, the cells were washed carefully of any residual ethanol with
PBS and incubated for at least 3 hours in a propidium iodine (PI)
solution composed of 50 mg/ml PI, 0.1% Triton X-100, 2.5 U/ml
RNase in PBS without Ca or MG (all from Sigma-Aldrich except
for the PBS which was from Gibco BRL/Invitrogen).
CFU-MK assay
Hundred thousand 10
5 whole BM cells were assessed for
megakaryocyte progenitor activity in a CFU-Mk assay, MegaCult-
C (Stem cell Technologies, Vancouver, CA) per the manufactur-
er’s instructions.
Phosphorylation analysis of signaling proteins
Phospho-flow analysis was performed on BM cells isolated from
129SvJ WT and SHIP
DIP/DIP. Cells were isolated on ice, after red
blood cell lysis, cells were stained for Lin
2c-kit
+CD41
+ using the
same antibody clones than mentioned above, except for c-kit
which was conjugated to PeCy7 instead of APC. Cells were then
directly fixed with Fix buffer (BD Biosciences) for 10 minutes at
37uC and washed with Perm/Wash buffer I (BD Biosciences).
After centrifugation, the cells were resuspended in Perm/Wash
buffer I. The appropriate phospho-antibody was added to the
cells, and incubated at RT for 30 minutes. The cells were then
washed twice in Perm/wash buffer I and stored in that same buffer
on ice until the time of acquisition The phospho-antibodies were
from BD Biosciences, anti-phospho-Stat3Y705 (clone 4/P-Stat3),
anti-phospho ERK1/2 T202/T204 (clone 20a), anti phosphor Akt
S473) (clone F29-763). The analysis was carried on a BD LSR II
(BD Biosciences).
Statistical analysis
Statistical analysis for each experiment consisted of the Mann-
Whitney test performed using the Prism software. For each
experiment, the number of individual mice analyzed is indicated
as ‘‘n’’ in the figure legends. All mice were analyzed individually
SHIP-Deficient Thrombopoiesis
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these experiments).
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